Back to RPRX
Aventail Capital Group, LP → RPRX
Aventail Capital Group, LP RPRX Position History
Royalty Pharma plc
Quarters held
4
Latest value
$9.4M
Q3 2026
Peak value
$60.1M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $60.1M |
| Q1 2026 | $20.3M |
| Q2 2026 | $10M |
| Q3 2026 | $9.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $9.4M | 193.5K | — | — |
| Q2 2026 | $10M | 214.6K | — | — |
| Q1 2026 | $20.3M | 396.0K | — | — |
| Q4 2025 | $60.1M | 1.57M | — | — |